After searching i can't believe there's no thread on this one.

Anyhow what about a bounce for tomorrow after some sort of analysts meeting?

Regards

Stan.

Liberum Capital Sell 578.25 545.00 545.00 Reiterates

Canaccord Genuity Buy 578.25 675.00 675.00 Reiterates

Credit Suisse reiterates underperform on Tate & Lyle, target cut from 600p to 550p.

Liberum Capital reiterates sell on Tate & Lyle, target cut from 545p to 505p

Looking at the chart, 550 looks fairly conservative ..

Liberum Capital Sell 564.50 545.00 505.00 Reiterates

Support at 560 but if that doesn't hold watch out below. I am watching with interest am worried 560 will not hold if FTSE has a couple of bad down days (and I think this is overdue)

FWIW, I guess folks think "Sugar" is yet another thing we shouldn't have... so TO is bound to suffer as our waistlines/teeth improve.
[TATE] really needs to find another business to wrap around what they do.
It's a product that's had its day....sure the sweetener Market could take over, but the writing is on the wall.... isn't it?

May finally have turned upwards today. 20p dividend a couple of weeds ago so chart not as horrible as it first looks

StockMarketWire.com
Tate & Lyle said its Q1 trading performance was in line with its expectations and guidance for the FY remains unchanged.

Speciality Food Ingredients made an encouraging start to the year and performed ahead of the comparative period.

The company continued in a statement:

"SPLENDA Sucralose performed solidly as we continued to pursue volume only where we see value. The consolidation of sucralose manufacturing into our facility in Alabama, USA, is progressing as planned supported by good customer engagement.

"Volume growth for Food Systems was ahead of the comparative period benefitting from the acquisition, last year, of Gemacom in Brazil. Volume across the balance of the Speciality Food Ingredients business was slightly behind the comparative period, with volume improving as we exited the quarter.

"We continued to take steps to address the impacts of the supply chain disruption experienced last year and we expect volume growth to strengthen through the remainder of the year as the additional capacity comes on-line in the second half. The volume of new products grew strongly in the quarter.

"Bulk Ingredients, excluding commodities (ethanol and co-products), performed steadily and slightly ahead of the comparative period supported by solid sweetener demand. However, this was more than offset by the impact of commodities, including the continuation of low US ethanol margins.

"The process of obtaining regulatory approval for the re-alignment of the Eaststarch joint venture in Europe is progressing well and we expect to complete this transaction around the end of the second quarter of the financial year."

SALE OF EU SUGARS; UPDATE ON LITIGATION
"As previously announced and disclosed in our 2015 Annual Report, American Sugar Holdings (ASR) raised a number of claims totalling in the region of $40 million relating to its acquisition of the Groups EU Sugars business in September 2010.

"A trial of these proceedings was held in the Commercial Court in London in early May 2015, with the judges verdict expected later in the year."

FINANCIAL POSITION AND BALANCE SHEET
"Net debt was slightly lower than the position at 31 March 2015 aided by the translation effects of a stronger sterling.

"Following the quarter end, on 21 July 2015, we priced a US$400 million debt private placement with notes to be issued maturing in 8, 10 and 12 years, extending the average maturity of our debt by approximately 2 years. The transaction is expected to complete on 29 October 2015."

Sugar staged the biggest one-day rally in more than a year Thursday as funds rushed to cover their bearish bets in the wake of stronger-than-expected U.S. economic growth numbers.

On the ICE Futures U.S. exchange, raw sugar futures for October delivery rallied 5% to 11.06 cents a pound. Sugar prices have recovered 6.4% since Aug. 24 when they tumbled to the lowest level in seven years.

"To me, it's just short covering," said Nick Gentile, managing partner at NickJen Capital Management, a commodity risk management firm. "There's no fundamental news out today (on sugar)."

Soft commodities were hammered in recent days amid a sharp selloff sweeping global financial markets, as traders were assessing the prospect of a slower Chinese economy and the ensuing disinflationary impact on the global growth.

Some participants in the commodity markets, especially those long-only funds, have liquidated their positions fearing slower demand for commodities could hurt prices even further.


I post this as it demonstrates the ebb and flow and change in perception of the bulls and bears on commodities in general. I am concerned that everywhere you look on commodities many who were long capitulated on the china new forcing the price down whilst the computerised black boxes kept selling on the downtrend.

Some of the charts now look like the downtrend has been breached and now the black boxes have to close and find buyers to close against

StockMarketWire.com
Tate & Lyle said, encouraged by its Q3 performance, it now expects the group's FY performance in constant currency to be modestly ahead of its expectations given at the time of its interims.

"The group continued to perform strongly in the third quarter with profit in constant currency ahead of the comparative period in both divisions," said Tate & Lyle in a statement.

"Speciality Food Ingredients performed in line with expectations while in Bulk Ingredients profit was ahead of our expectations," it added.

In Speciality Food Ingredients, excluding Food Systems and SPLENDA Sucralose, profit was ahead of the comparative period benefiting from good commercial execution and strong manufacturing performance.

"Underlying volume was broadly in line with the comparative period. As in the first half, demand in North America continued to be soft with volume lower, whilst in Europe, Middle East and Africa underlying volume growth was robust."

Strong volume growth in Latin America largely offset weaker demand in Asia Pacific.

Food Systems profit continued to be held back by lower volume and SPLENDA Sucralose profit was ahead of the comparative period benefiting from the consolidation of production to a single facility.

In Bulk Ingredients, North American sweetener volume remained robust. The calendar 2017 bulk sweetener pricing round is now substantially complete and is expected to deliver modest margin gains in the fourth quarter.

"Commodities performance was satisfactory and somewhat ahead of our expectations," said Tate & Lyle.

StockMarketWire.com
Tate & Lyle grew its adjusted pre-tax profit by 13% at constant currency to £161 million in the six months to 30 September.

Sales grew by 6% to £1.4 billion on a statutory basis but were flat at constant currency.

The Speciality Foods division grew its operating profit by 4% at constant currency to £104 million, with volumes up 3%.

North America returning to modest growth, which the company said was driven by its approach of focusing on higher growth sub-categories and customer channels, while continuing to provide high-quality service to larger customers.

Bulk Ingredients operating profit rose by 36% at constant currency to £93 million, with volumes up 2% driven by North American sweetener growth and reflecting good contract compliance.

Sales at constant currency were down 2% in Speciality Foods and flat in Bulk Ingredients.

Net debt at £371m was £81m lower than at 31 March 2017, with strong cash flow generation and the beneficial impact of foreign exchange translation of US dollar debt, partially offset by the final 2017 dividend payment of £92m.

The company has lifted its interim dividend from 8.2p to 8.4p per share.

Javed Ahmed, chief executive, said: "Speciality Food Ingredients delivered broad-based volume growth in the core business, including North America despite market conditions in that region remaining challenging. New Products once again delivered double digit sales growth as customers continue to seek innovative solutions to reduce sugar, calories and fat in food and drink.

"Bulk Ingredients had another period of excellent performance, well ahead of a strong comparative period, with improved overall earnings resulting from disciplined commercial execution and margin expansion.

"Turning to the outlook, we expect underlying adjusted profit before tax in constant currency for the full year to be modestly higher than we anticipated coming into the year driven by the strong first half performance"

Just a spoonful of Sugar.

Unloved but I like them.

Good market reaction to today's results.